GlassScriptPrepare for your visit
Marlee A Fallon
Medical · Fayetteville, NY · NPI 1578050480
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,226.75
in general payments reported to CMS, 2019-2025 · $330 in 2025
The $330 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Who reported paying
General payments only, top 6 by amount.
- Glaxosmithkline, LLC. $366.91
- Genzyme Corporation $218.01
- Astrazeneca Pharmaceuticals LP $172.22
- Amgen INC. $108.57
- Pfizer INC. $90.25
- Csl Behring $42.79
Drugs and devices associated with these payments
Dupixent Nucala Tezspire Fasenra Octagam Immune Globulin (Human) Cutaquig Panzyga Trelegy Ellipta Andembry Oralair Dawnzera Ruconest
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Marlee Fallon listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11222113/marlee-a-fallon